Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
FIGS Announces Date of Third Quarter 2026 Earnings Release, Conference Call and Webcast
-
Amplitude Appoints Statsig Founder Vijaye Raji to Board of Directors
-
FVCBankcorp, Inc. Announces Quarterly Cash Dividend
-
Teradata Announces 2026 Third Quarter Earnings Release Date
-
Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
-
EY Survey: Cost Per Payroll Error Climbs to $339 Average for Companies
-
Albertsons® Companies, Inc. Appoints Harmit Singh to Board of Directors
-
Spruce Biosciences to Participate in the Craig-Hallum Biotech Catalyst Conference
-
Genpact Limited Board Declares Quarterly Cash Dividend
-
Vertex to Announce Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
-
MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors
-
Medallion Financial Corp. to Report 2026 Third Quarter Results on Thursday, October 29, 2026
-
Westrock Coffee Company to Report Third Quarter 2026 Financial Results on November 5th, 2026
-
onsemi to Announce Third Quarter Financial Results
-
IB Acquisition Corp. Announces Date of 2026 Annual Meeting of Stockholders
-
Goosehead Insurance, Inc. Reschedules Investor Day to March 31, 2027
-
Appian To Announce Third Quarter 2026 Financial Results on November 5, 2026
-
Middlesex Water Company to Report Third Quarter 2026 Earnings on October 29
-
Taboola to Announce Third Quarter Financial Results on November 4, 2026
-
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
-
Brilliant Earth to Report Third Quarter 2026 Financial Results on November 5th
-
The Honest Company to Report Third Quarter 2026 Financial Results on November 5, 2026
-
Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026
-
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
-
Ingredion to Release 2026 Third Quarter Financial Results On November 5, 2026
-
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026
-
Dropbox to Announce Third Quarter 2026 Earnings Results
-
STACK Celebrates Inaugural Critical Operations Development Academy Graduating Class in Santa Teresa, New Mexico
-
Interactive Brokers Group Announces 3Q2026 Results
-
TwinStrand Biosciences Announces Second U.S. Patent Trial and Appeal Board Decision Upholding All Claims of TwinStrand’s ‘127 Patent
-
CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026
-
Tempus to Report Third Quarter 2026 Financial Results on November 2
-
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Amazon.com to Webcast Third Quarter 2026 Financial Results Conference Call
-
Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List
-
Freehold Royalties Declares Dividend for October 2026
-
Cheetah Net Supply Chain Service Inc. Statement Regarding Preliminary Stockholder Consent Solicitation
-
American Coastal Insurance Corporation Schedules Third Quarter Financial Results and Conference Call
-
No Rest. No Peace: Guns of Eschaton Launches December 8, 2026
-
Wise Group plc reports Q2 FY27 Results
-
Goldhills Holding Ltd. Announces Non-Brokered Private Placement of up to $500,000
-
Shiba Inu Price Prediction: SHIB Slides Near $0.000005 as Remittix’s Crypto-to-Bank Tests Add a Utility Hook
-
Bitcoin News: Strategy’s Treasury Reaches 848,250 BTC as Remittix Brings an Earlier-Stage Payments Bet to Market
-
Facilis Technology Powers Up NAB Show New York 2026 with Breakthrough Network Performance, Next-Gen Security, and Deep Media Composer 2026.8 Integration
-
MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance
-
Kish Bancorp, Inc. Reports Record Net Income of $6.4 Million, or $2.11 Per Share, for the Third Quarter of 2026
-
¡HOLA! AMERICAS ANNOUNCES MUSICAL LINEUP FOR LATINA POWERHOUSE 100 GALA
-
Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026
-
Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome
-
byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination


